Skip to main content
Ipsen Home Page
Press shift tab to select search category

Loading...
  • Press Releases
  • Investors
  • Partnering
  • Careers arrow down
      < Back
    • Careers
    • Careers
    • Working at Ipsen
  • Press shift tab to select search category

    Loading...
  • English  EN     Français  FR     EN  arrow_down
    • English EN
    • Français FR
  • Global Canada
    < Back
    • Global EN FR
    • Annual Report EN FR
    • Americas
    • Asia Pacific
    • Europe
    • United States
    • Brazil
    • Canada
    • Mexico
    • Australia
    • China
    • Singapore
    • South Korea
    • Japan
    • Belgium
    • Ukraine
    • UK
    • Germany
    • France
    • Nordics
    • Greece
    • Italy
    • Netherlands
    • Spain
    • Poland
    • Russia
    • Czech Republic
    • Switzerland
    • Austria
  • Home
  • Companyarrow down
      < Back
    • Company
    • Who We Are
    • Leadership
    • Our History
  • Sciencearrow down
      < Back
    • Science
    • Areas of Focus
    • Products
    • Clinical Trials
    • R&D
    • Grant Requests
    • Investigator Sponsored Studies
  • Sustainabilityarrow down
      < Back
    • Sustainability
    • Sustainability
    • Environment
    • People
    • Governance
    • Charitable Contributions
  • Patients
  1. Home
  2. Company – Leadership

Leadership

Meet our leadership team

Ed Dybka

Ed Dybka

General Manager

Ipsen Canada

Corinne Barr

Corinne Barr

Senior Director

Oncology Business Unit

Brad Carter

Brad Carter

Senior Director

Finance and Supply Chain

Phyllis Ioannou

Phyllis Ioannou

Senior Director

Value & Access and Patient Support Programs

Bryan Laskey

Bryan Laskey

Senior Director

Neuroscience & Rare Disease Business Unit

Tim Noble

Tim Noble

Senior Director

Business Operations & Strategy

Walid Shammas

Walid Shammas

Senior Director

Medical and Regulatory Affairs

Suki Wiltman

Suki Wiltman

Vice President

Global Business Ethics

Kendra Baillie

Kendra Baillie

Senior Director

Human Resources, North America

IPN price

€102.40

 €-1.30 (-1.25%)

  • Investors
  • Partnering
  • Careers
  • Who We Are
  • Sustainability
  • Contact us

Canada
Linkedin Facebook Instagram Youtube
  • Terms of Use
  • Cookie Policy
  • Privacy Policy
  • Accessibility

© Ipsen Pharma. All rights reserved - 2025

You are now leaving the Ipsen Canada website. To continue, please click Continue.

Continue